LMNA-PRIORITY
The PRIORITY project—short for cardio-laminoPathy: fRom pathomechanIsms tO peRsonalIzed TherapY—is a major international research initiative funded by the Leducq Foundation with an $8 million grant. Launched in January 2025, it focuses on LMNA-related dilated cardiomyopathy (LMNA-DCM), a severe hereditary heart condition caused by mutations in the LMNA gene. These mutations disrupt the structure and function of the cell nucleus, leading to progressive heart failure and arrhythmias.
Join our newsletter
Stay updated on the latest LMNA research and breakthroughs.
The PRIORITY Project
The PRIORITY Project brings together leading LMNA researchers and clinicians to identify shared goals, align research strategies, and promote faster translation of scientific insights into meaningful therapies for patients.
Learn More →
About us
LMNA PRIORITY is an international science-driven initiative focused on accelerating research and collaboration around LMNA-related diseases. We connect experts across disciplines to advance understanding, improve diagnostics, and drive therapeutic innovation.
Learn More →
News & Updates
Stay informed about the latest developments in LMNA research, clinical trials, scientific meetings, and community initiatives. We share progress, insights, and opportunities to engage with the LMNA research community.
Learn More →
Our mission
Understanding and treating LMNA-related cardiac and neuromuscular diseases
LMNA PRIORITY unites researchers, clinicians, and advocates to accelerate scientific discovery for LMNA-related cardiac and neuromuscular diseases. By fostering collaboration, data sharing, and patient-centered research, we aim to drive meaningful progress toward understanding and treating these rare but impactful conditions.
PRIORITY
Cardio-laminoPathy: fRom pathomechanIsms tO peRsonalIzed TherapY
